scispace - formally typeset
N

Natalia Rosso

Researcher at AREA Science Park

Publications -  49
Citations -  1409

Natalia Rosso is an academic researcher from AREA Science Park. The author has contributed to research in topics: Fatty liver & Steatohepatitis. The author has an hindex of 19, co-authored 43 publications receiving 1109 citations. Previous affiliations of Natalia Rosso include University of Trieste.

Papers
More filters
Journal ArticleDOI

Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future.

TL;DR: Find an inexpensive method to diagnose and stage fatty liver and related metabolic diseases represent an economic burden and a translational approach with the use of cell and/or animal models could help to reach this goal.
Journal ArticleDOI

Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease

TL;DR: The exposure of hepatocytes to fatty acids elicits inflammation, increase of oxidative stress, apoptosis and production of fibrogenic cytokines, which support a primary role of FFA in the pathogenesis of NAFLD and NASH.
Journal ArticleDOI

Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance.

TL;DR: Cytoplasmic expression of APE1/Ref-1 is increased in HCC and is associated with a lower degree of differentiation and a shorter survival time, pointing to the use of the cytoplasmaic localization of APe1/ ref-1 as a prognostic marker for HCC.
Journal ArticleDOI

The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade

TL;DR: The increased nuclear-enriched/cytoplasmic protein ratio of e EF1A and the marked raise of the expression of both eEF1A forms in JHH6 compared to HepG2 are shown, suggesting the possibility that eEF 1A forms might become a relevant markers related to HCC tumor phenotype.
Journal ArticleDOI

Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness

TL;DR: Evidence is provided that Gal-1 plays a role in hepatocellular carcinoma cell migration and invasion, and it is suggested that further studies should be conducted to fully establish the role of Gal-2 and evaluateGal-1 as a potential molecular therapeutic target.